Please login to the form below

Not currently logged in
Email:
Password:

BioAtla

This page shows the latest BioAtla news and features for those working in and with pharma, biotech and healthcare.

Pfizer signs $1bn cancer antibody deal with BioAtla

Pfizer signs $1bn cancer antibody deal with BioAtla

Using a CAB-ADC against CTLA4 that only activates around tumours could be a big advance, according to BioAtla. ... San Diego-based BioAtla also has laboratories in China and in June raised $30m from a Chinese investment group.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics